US Biomax, Inc.

MC8010

Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases/80 cores

Microarray Panel:Multiple organ carcinoma tissue microarray, containing 20 cases of lung carcinoma (10 each of squamous cell carcinoma and adenocarcinoma), 20 colon adenocarcinoma, 20 stomach carcinoma (16 adenocarcinoma, 4 signet-ring cell carcinoma), 20 breast carcinoma (5 intraductal carcinoma, 1 lobular carcinoma in situ, 6 papillary carcinoma, 4 each of solid adenocarcinoma and scirrhous carcinoma), single core per case
Cores:80
Cases:80
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun  
B Lun Lun Lun Lun Lun Lun Lun Lun Lun Lun  
C Col Col Col Col Col Col Col Col Col Col  
D Col Col Col Col Col Col Col Col Col Col  
E Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
F Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
G Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
H Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Marked point
Legend: Bre - Breast, Col - Colon, Lun - Lung, Sto - Stomach

- Malignant tumor, - Malignant tumor (stage 0), - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage IV), - Malignant tumor (stage Ia), - Malignant tumor (stage Ib)

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 43 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
A2 2 M 60 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
A3 3 M 66 Lung Squamous cell carcinoma IIIa T2N2M0 Malignant
A4 4 M 66 Lung Squamous cell carcinoma 3 I T1N1M0 Malignant
A5 5 M 67 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
A6 6 M 71 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
A7 7 M 54 Lung Squamous cell carcinoma 3 IIIa T2N2M0 Malignant
A8 8 M 43 Lung Squamous cell carcinoma 3 I T2N0M0 Malignant
A9 9 M 52 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
A10 10 M 69 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
B1 11 M 57 Lung Papillary adenocarcinoma 1 I T2N0M0 Malignant
B2 12 F 64 Lung Adenocarcinoma 2 I T2N0M0 Malignant
B3 13 M 58 Lung Adenocarcinoma 2 I T2N0M0 Malignant
B4 14 M 49 Lung Adenocarcinoma 2 I T2N0M0 Malignant
B5 15 M 42 Lung Adenocarcinoma 2 IIIa T3N1M0 Malignant
B6 16 F 72 Lung Adenocarcinoma 3 II T2N1M0 Malignant
B7 17 M 50 Lung Adenocarcinoma 3 I T2N0M0 Malignant
B8 18 F 58 Lung Adenocarcinoma 3 I T2N0M0 Malignant
B9 19 M 53 Lung Adenocarcinoma 3 I T2N0M0 Malignant
B10 20 M 59 Lung Adenocarcinoma 3 II T2N1M0 Malignant
C1 21 M 48 Colon Adenocarcinoma 1 I T2N0M0 Malignant
C2 22 F 46 Colon Papillary adenocarcinoma 1 II T3N0M0 Malignant
C3 23 F 82 Colon Tubular papillary adenocarcinoma 1 II T3N0M0 Malignant
C4 24 F 62 Colon Tubular papillary adenocarcinoma 1 II T4N0M0 Malignant
C5 25 F 66 Colon Tubular adenocarcinoma 1 I T2N0M0 Malignant
C6 26 F 41 Colon Tubular adenocarcinoma 1 II T3N0M0 Malignant
C7 27 M 60 Colon Tubular papillary adenocarcinoma 1 III T3N1M0 Malignant
C8 28 M 54 Colon Tubular adenocarcinoma 2 II T3N0M0 Malignant
C9 29 F 50 Colon Tubular papillary adenocarcinoma 2 II T3N0M0 Malignant
C10 30 F 76 Colon Mucinous adenocarcinoma 1 III T3N1M0 Malignant
D1 31 F 58 Colon Adenocarcinoma 2 III T3N1M0 Malignant
D2 32 M 56 Colon Adenocarcinoma 2 III T3N1M0 Malignant
D3 33 M 80 Colon Adenocarcinoma 2 III T4N2M0 Malignant
D4 34 F 72 Colon Adenocarcinoma 1–2 II T3N0M0 Malignant
D5 35 F 41 Colon Adenocarcinoma 1–2 III T3N1M0 Malignant
D6 36 M 74 Colon Adenocarcinoma 3 II T3N0M0 Malignant
D7 37 F 65 Colon Adenocarcinoma 3 I T2N0M0 Malignant
D8 38 F 39 Colon Adenocarcinoma 3 II T3N0M0 Malignant
D9 39 M 52 Colon Adenocarcinoma 3 II T3N0M0 Malignant
D10 40 M 56 Colon Adenocarcinoma 3 IV T3N0M1 Malignant
E1 41 M 69 Stomach Papillary adenocarcinoma 1 II T3N0M0 Malignant
E2 42 F 70 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
E3 43 F 50 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
E4 44 M 64 Stomach Adenocarcinoma 2 IIIa T3N1M0 Malignant
E5 45 M 65 Stomach Adenocarcinoma 1–2 Ib T2N0M0 Malignant
E6 46 M 63 Stomach Adenocarcinoma (smooth muscle tissue) II T3N0M0 Malignant
E7 47 M 75 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
E8 48 M 54 Stomach Adenocarcinoma 2 Ia T1N0M0 Malignant
E9 49 M 67 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
E10 50 M 41 Stomach Adenocarcinoma (chronic inflammation of smooth muscle) II T3N0M0 Malignant
F1 51 M 56 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
F2 52 M 50 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
F3 53 M 63 Stomach Signet-ring cell carcinoma (sparse) Ib T2N0M0 Malignant
F4 54 F 32 Stomach Signet-ring cell carcinoma IIIa T3N1M0 Malignant
F5 55 M 61 Stomach Signet-ring cell carcinoma IIIa T3N1M0 Malignant
F6 56 M 51 Stomach Signet-ring cell carcinoma II T3N0M0 Malignant
F7 57 M 67 Stomach Mucinous adenocarcinoma 2–3 II T3N0M0 Malignant
F8 58 F 59 Stomach Mucinous adenocarcinoma 3 IIIa T3N1M0 Malignant
F9 59 M 49 Stomach Mucinous adenocarcinoma with singnet-ring cell carcinoma 3 II T3N0M0 Malignant
F10 60 F 70 Stomach Mucinous adenocarcinoma 3 II T3N0M0 Malignant
G1 61 F 67 Breast Non-invasive solid intraductal carcinoma 0 TisN0M0 Malignant
G2 62 F 45 Breast Non-invasive papillary-tubular intraductal carcinoma 0 TisN0M0 Malignant
G3 63 F 43 Breast Non-invasive papillary-tubular intraductal carcinoma 0 TisN0M0 Malignant
G4 64 F 53 Breast Non-invasive papillary-tubular intraductal carcinoma 0 TisN0M0 Malignant
G5 65 F 45 Breast Non-invasive papillary-tubular intraductal carcinoma 0 TisN0M0 Malignant
G6 66 F 48 Breast Lobular carcinoma in situ 0 TisN0M0 Malignant
G7 67 F 39 Breast Invasive papillary carcinoma IIa T2N0M0 Malignant
G8 68 F 72 Breast Invasive papillary carcinoma I T1N0M0 Malignant
G9 69 F 50 Breast Invasive papillary carcinoma IIa T2N0M0 Malignant
G10 70 F 55 Breast Invasive papillary carcinoma IIa T2N0M0 Malignant
H1 71 F 67 Breast Invasive papillary carcinoma 2 IIa T2N0M0 Malignant
H2 72 F 67 Breast Invasive papillary carcinoma 2 IIa T2N0M0 Malignant
H3 73 F 42 Breast Invasive solid-tubular duct adenocarcinoma 2 IIa T2N0M0 Malignant
H4 74 F 50 Breast Invasive solid-tubular duct adenocarcinoma 2 IIb T2N1M0 Malignant
H5 75 F 31 Breast Invasive solid-tubular duct adenocarcinoma 2 IIa T2N0M0 Malignant
H6 76 F 41 Breast Solid duct adenocarcinoma 2 IIa T2N0M0 Malignant
H7 77 F 51 Breast Scirrhous carcinoma IIb T3N1M0 Malignant
H8 78 F 50 Breast Scirrhous carcinoma IIb T2N1M0 Malignant
H9 79 F 47 Breast Scirrhous carcinoma IIb T3N1M0 Malignant
H10 80 F 64 Breast Scirrhous carcinoma IIa T2N0M0 Malignant
M 58 Skin Malignant melanoma (tissue marker) Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array: